Info: Read More
  • 中药标准品生产商,产品定制服务
  • 芦荟苦素

    Aloesin

    芦荟苦素
    产品编号 CFN91659
    CAS编号 30861-27-9
    分子式 = 分子量 C19H22O9 = 394.37
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Flavonoids
    植物来源 The herbs of Aloe arborescens Mill.
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    芦荟苦素 CFN91659 30861-27-9 1mg QQ客服:2056216494
    芦荟苦素 CFN91659 30861-27-9 5mg QQ客服:2056216494
    芦荟苦素 CFN91659 30861-27-9 10mg QQ客服:2056216494
    芦荟苦素 CFN91659 30861-27-9 20mg QQ客服:2056216494
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • University of Zurich (Switzerland)
  • Technical University of Denmark (Denmark)
  • Sri Ramachandra University (India)
  • University of Medicine and Pharmacy (Romania)
  • Northeast Normal University Changchun (China)
  • University of Padjajaran (Indonesia)
  • Vin?a Institute of Nuclear Sciences (Serbia)
  • Weizmann Institute of Science (Israel)
  • Harvard University (USA)
  • Universidade Federal de Goias (UFG) (Brazil)
  • Mahatma Gandhi University (India)
  • Institute of Pathophysiology Medical University of Vienna (Austria)
  • Universiti Kebangsaan Malaysia (Malaysia)
  • Worcester Polytechnic Institute (USA)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • J of the Korean Society of Food Science and Nutrition2016, 45(7):1017-1025
  • Molecules. 2013, 18(7):7376-88
  • Nutrients2020, 12(3):811.
  • J.Acta Agriculturae Scandinavica2017, 571-575
  • Biol Pharm Bull.2021, 44(12):1891-1893.
  • J Ethnopharmacol.2017, 209:305-316
  • Nutraceuticals2022, 2(3),150-161
  • Phytother Res.2022, 35844057.
  • Antioxidants (Basel).2021, 10(8):1300.
  • Cell Physiol Biochem.2017, 43(4):1425-1435
  • Toxins (Basel).2019, 11(10):E575
  • Front Pharmacol.2021, 12:762829.
  • Pharm Biol.2022, 60(1):2040-2048.
  • Chemistry of Natural Compounds2020, 56,423-426
  • Journal of Research in Pharmacy.2022, 26(6):p1752-1757.
  • American Association for Anatomy2020, doi: 10.1002.
  • Food Res Int.2019, 123:125-134
  • Biomed Pharmacother.2020, 128:110318.
  • Advances in Traditional Medicine 2021, 21:779-789.
  • Natural Product Communications2020, doi: 10.1177.
  • Cell Chem Biol.2019, 26(1):27-34
  • Food Science and Biotechnology2023, 2023:1007
  • Genes (Basel).2021, 12(7):1024.
  • ...
  • 生物活性
    Description: Aloesin (Aloeresin) is an active constituent of the herb aloe vera and displays anti-inflammatory activity, ultraviolet protection, inhibits tyrosinase (IC50 = 0.9 mM)activity and antibacterium effects. Aloesin exerts its anticancer effect through the MAPK signaling pathway
    In vitro:
    Anal Cell Pathol (Amst) . 2017;2017:8158254.
    Aloesin Suppresses Cell Growth and Metastasis in Ovarian Cancer SKOV3 Cells through the Inhibition of the MAPK Signaling Pathway[Pubmed: 28702312]
    Aloesin is an active constituent of the herb aloe vera and plays a crucial role in anti-inflammatory activity, ultraviolet protection, and antibacterium. We investigated the role and possible mechanisms of aloesin in the cell growth and metastasis of ovarian cancer. It was found that aloesin inhibited cell viability and cell clonality in a dose-dependent manner. It arrests the cell cycle at the S-phase and induced apoptosis in SKOV3 cells. In an in vivo experiment, it was observed that aloesin inhibited tumor growth. Moreover, it inhibited migration and invasion of cancer in SKOV3 cells. Interestingly, members from the mitogen-activated protein kinase (MAPK) signaling family became less phosphorylated as the aloesin dose increased. This suggests that aloesin exerts its anticancer effect through the MAPK signaling pathway. Our data also highlights the possibility of using aloesin as a novel therapeutic drug for ovarian cancer treatment.
    Phytomedicine . 2017 May 15;28:19-26.
    Aloesin from Aloe vera accelerates skin wound healing by modulating MAPK/Rho and Smad signaling pathways in vitro and in vivo[Pubmed: 28478809]
    Background: Cutaneous wound healing is a complex process involving various regulatory factors at the molecular level. Aloe vera is widely used for cell rejuvenation, wound healing, and skin moisturizing. Hypothesis/purpose: This study aimed to investigate the effects of aloesin from Aloe vera on cutaneous wound healing and mechanisms involved therein. Study design: This study consisted of both in vitro and in vivo experiments involving skin cell lines and mouse model to demonstrate the wound healing effects of aloesin by taking into account several parameters ranging from cultured cell migration to wound healing in mice. Methods: The activities of Smad signaling molecules (Smad2 and Smad3), MAPKs (ERK and JNK), and migration-related proteins (Cdc42, Rac1, and α-Pak) were assessed after aloesin treatment in cultured cells (1, 5 and 10μM) and mouse skin (0.1% and 0.5%). We also monitored macrophage recruitment, secretion of cytokines and growth factors, tissue development, and angiogenesis after aloesin treatment using IHC analysis and ELISAs. Results: Aloesin increased cell migration via phosphorylation of Cdc42 and Rac1. Aloesin positively regulated the release of cytokines and growth factors (IL-1β, IL-6, TGF-β1 and TNF-α) from macrophages (RAW264.7) and enhanced angiogenesis in endothelial cells (HUVECs). Aloesin treatment accelerated wound closure rates in hairless mice by inducing angiogenesis, collagen deposition and granulation tissue formation. More importantly, aloesin treatment resulted in the activation of Smad and MAPK signaling proteins that are key players in cell migration, angiogenesis and tissue development. Conclusion: Aloesin ameliorates each phase of the wound healing process including inflammation, proliferation and remodeling through MAPK/Rho and Smad signaling pathways. These findings indicate that aloesin has the therapeutic potential for treating cutaneous wounds.
    Clin Exp Dermatol . 2002 Sep;27(6):513-515.
    Aloesin inhibits hyperpigmentation induced by UV radiation[Pubmed: 12372097]
    Skin hyperpigmentation is caused by the overproduction of melanin pigment, which is synthesized by the action of tyrosinase. We recently reported that aloesin inhibits tyrosinase activity. The present study was undertaken to test the inhibitory effect of aloesin on pigmentation in human skin after UV radiation. Experimental subjects were UV-irradiated (210 mJ) on the inner forearm. UV-irradiated regions were assigned to four groups: vehicle control, aloesin treated, arbutin treated, and aloesin and arbutin treated. Aloesin and/or arbutin were administered four times a day for 15 days. Aloesin treatment suppressed pigmentation by 34%, arbutin by 43.5%, and the cotreatment by 63.3% compared with the control (n = 15; P < 0.05). Moreover, aloesin treatment showed pigmentation suppression in a dose-dependent manner (n = 7; P < 0.05). These results raise the possibility that aloesin may be used as an agent that inhibits melanin formation induced by UV radiation.
    Regul Toxicol Pharmacol . 2011 Nov;61(2):215-221.
    In vitro and in vivo assessment of the genotoxic activity of aloesin[Pubmed: 21821088]
    Aloesin is a chromone that is a component of Aloe spp. It may have potential as a functional food ingredient as it has been shown to likely have beneficial effects in persons in a pre-diabetic state or who have metabolic syndrome. In this study the safety of aloesin has been evaluated using a series of in vitro and in vivo genotoxicity assays including, bacterial mutation, mammalian cell cytogenetic, and mouse micronucleus tests. Aloesin did not induce reverse mutations in Salmonella typhimurium and Escherichia coli at any of the tested dose levels up to 10,000 μg/plate. Similarly, aloesin did not increase the incidence of chromosome aberrations when incubated with Chinese hamster lung cells at any of the tested concentrations up to 10,000 μg/mL. In vivo, there was no effect of aloesin on the incidence of micronucleated erythrocytes following oral administration on two consecutive days at doses up to 5000 mg/kg body weight. There was no evidence of toxicity to bone marrow. The results of these studies demonstrate that aloesin is without genotoxic potential.
    Biochem Mol Biol Int . 1997 Feb;41(2):285-292.
    Aloesin up-regulates cyclin E/CDK2 kinase activity via inducing the protein levels of cyclin E, CDK2, and CDC25A in SK-HEP-1 cells[Pubmed: 9063568]
    In the present study, we show that aloesin, which is a low molecular weight ingredients present in Aloe vera, stimulates the proliferation of cultured human hepatoma SK-HEP-1 cells. The incorporation of [3H] thymidine into DNA in the cell cultures was significantly increased at a dose of 10 microM aloesin. The aloesin-induced DNA synthesis appears to require newly synthesized proteins because cycloheximide treatment blocked the DNA synthesis evoked by this compound. We then examined whether this compound increases the intracellular levels of cell cycle regulators by immunoblotting. The data showed that aloesin increased the levels of cyclin E, CDK2, and CDC25A in SK-HEP-1 cells. In addition, immuno-complex kinase assays showed that aloesin up-regulated the enzyme activity of cyclin E/CDK2 kinase in a dose-dependent manner. Collectively, these results suggest that aloesin stimulates the proliferation of SK-HEP-1 cells by inducing the intracellular levels of cyclin E/CDK2 kinase complex and CDC25A, which, together, result in the up-regulation of cyclin E-dependent kinase activity.
    Fitoterapia . 2021 Apr;150:104828.
    Anti-tyrosinase activity of South African Aloe species and isolated compounds plicataloside and aloesin[Pubmed: 33434632]
    Tyrosinase is the key enzyme in the production of melanin. Tyrosinase inhibitors have gained interest in the cosmetics industry to prevent hyperpigmentation and skin-related disorders by inhibiting melanin production. It has been reported that several Aloe species exhibit anti-tyrosinase efficacy in vitro. In this study, the exudates of thirty-nine South African Aloe species were screened to identify species and compounds with anti-tyrosinase activity. Qualitative screening revealed that twenty-nine Aloe species exhibited tyrosinase inhibition activity with one to three active bands. Quantitative screening was performed for 29 species and expressed as IC50 values. Three species were further analysed and subsequently, aloesin and aloeresin A was isolated from A. ferox and plicataloside from A. plicatilis and A. chabaudii. Aloeresin A was determined to be a substrate of mushroom tyrosinase. Dose-response assays showed that aloesin (IC50 = 31.5 μM) and plicataloside (IC50 = 84.1 μM) exhibited moderate to weak activity. Molecular docking scores for plicataloside were considerably lower than for aloesin (P < 0.01), confirming its lower IC50. Several Aloe species may have potential for the management of hyperpigmentation or as a skin lightening agent. This is the first report showing that plicataloside, present in A. plicatilis and A. chabaudii, exhibits anti-tyrosinase activity.
    In vivo:
    Phytomedicine . 2017 May 15;28:19-26.
    Aloesin from Aloe vera accelerates skin wound healing by modulating MAPK/Rho and Smad signaling pathways in vitro and in vivo[Pubmed: 28478809]
    Background: Cutaneous wound healing is a complex process involving various regulatory factors at the molecular level. Aloe vera is widely used for cell rejuvenation, wound healing, and skin moisturizing. Hypothesis/purpose: This study aimed to investigate the effects of aloesin from Aloe vera on cutaneous wound healing and mechanisms involved therein. Study design: This study consisted of both in vitro and in vivo experiments involving skin cell lines and mouse model to demonstrate the wound healing effects of aloesin by taking into account several parameters ranging from cultured cell migration to wound healing in mice. Methods: The activities of Smad signaling molecules (Smad2 and Smad3), MAPKs (ERK and JNK), and migration-related proteins (Cdc42, Rac1, and α-Pak) were assessed after aloesin treatment in cultured cells (1, 5 and 10μM) and mouse skin (0.1% and 0.5%). We also monitored macrophage recruitment, secretion of cytokines and growth factors, tissue development, and angiogenesis after aloesin treatment using IHC analysis and ELISAs. Results: Aloesin increased cell migration via phosphorylation of Cdc42 and Rac1. Aloesin positively regulated the release of cytokines and growth factors (IL-1β, IL-6, TGF-β1 and TNF-α) from macrophages (RAW264.7) and enhanced angiogenesis in endothelial cells (HUVECs). Aloesin treatment accelerated wound closure rates in hairless mice by inducing angiogenesis, collagen deposition and granulation tissue formation. More importantly, aloesin treatment resulted in the activation of Smad and MAPK signaling proteins that are key players in cell migration, angiogenesis and tissue development. Conclusion: Aloesin ameliorates each phase of the wound healing process including inflammation, proliferation and remodeling through MAPK/Rho and Smad signaling pathways. These findings indicate that aloesin has the therapeutic potential for treating cutaneous wounds.
    Regul Toxicol Pharmacol . 2011 Nov;61(2):215-221.
    In vitro and in vivo assessment of the genotoxic activity of aloesin[Pubmed: 21821088]
    Aloesin is a chromone that is a component of Aloe spp. It may have potential as a functional food ingredient as it has been shown to likely have beneficial effects in persons in a pre-diabetic state or who have metabolic syndrome. In this study the safety of aloesin has been evaluated using a series of in vitro and in vivo genotoxicity assays including, bacterial mutation, mammalian cell cytogenetic, and mouse micronucleus tests. Aloesin did not induce reverse mutations in Salmonella typhimurium and Escherichia coli at any of the tested dose levels up to 10,000 μg/plate. Similarly, aloesin did not increase the incidence of chromosome aberrations when incubated with Chinese hamster lung cells at any of the tested concentrations up to 10,000 μg/mL. In vivo, there was no effect of aloesin on the incidence of micronucleated erythrocytes following oral administration on two consecutive days at doses up to 5000 mg/kg body weight. There was no evidence of toxicity to bone marrow. The results of these studies demonstrate that aloesin is without genotoxic potential.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 2.5357 mL 12.6784 mL 25.3569 mL 50.7138 mL 63.3922 mL
    5 mM 0.5071 mL 2.5357 mL 5.0714 mL 10.1428 mL 12.6784 mL
    10 mM 0.2536 mL 1.2678 mL 2.5357 mL 5.0714 mL 6.3392 mL
    50 mM 0.0507 mL 0.2536 mL 0.5071 mL 1.0143 mL 1.2678 mL
    100 mM 0.0254 mL 0.1268 mL 0.2536 mL 0.5071 mL 0.6339 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    Undulatoside A; Undulatoside A CFN96467 58108-99-9 C16H18O9 = 354.31 5mg QQ客服:2159513211
    Drynachromoside A; Drynachromoside A CFN92909 1507388-29-5 C22H28O13 = 500.45 5mg QQ客服:1413575084
    Cypellocarpin C; Cypellocarpin C CFN89273 294856-66-9 C26H32O11 = 520.53 5mg QQ客服:2159513211
    Eucamalduside A; Eucamalduside A CFN89020 1287220-29-4 C26H32O11 = 520.53 5mg QQ客服:2159513211
    Monnieriside A; Monnieriside A CFN92910 1401807-73-5 C16H18O10 = 370.31 5mg QQ客服:1457312923
    Cnidimol A ; Cnidimol A CFN96860 103629-80-7 C15H16O5 = 276.28 5mg QQ客服:215959384
    番樱桃素; Eugenin CFN90808 480-34-2 C11H10O4 = 206.2 10mg QQ客服:215959384
    8-Methyleugenitol; 8-Methyleugenitol CFN96198 41682-21-7 C12H12O4 = 220.2 5mg QQ客服:2159513211
    5,7-二羟基-2-(1-甲基乙基)-4H-1-苯并吡喃-4-酮; 5,7-Dihydroxy-2-isopropylchromone CFN97544 96552-59-9 C12H12O4 = 220.2 5mg QQ客服:2056216494
    8-Glucosyl-5,7-dihydroxy-2-(1-methylpropyl)chromone; 8-Glucosyl-5,7-dihydroxy-2-(1-methylpropyl)chromone CFN89218 188818-27-1 C19H24O9 = 396.39 5mg QQ客服:1457312923

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产